Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016‐17
Open Access
- 30 July 2020
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 14 (6) , 671-677
Abstract
Background: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016‐2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV.Methods: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT‐PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories.Results: Laboratories performed well using the CDC RSV rRT‐PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false‐positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs.Conclusions: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1127419)
This publication has 21 references indexed in Scilit:
- Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and TreatmentClinical Microbiology Reviews, 2017
- Vaccines Against Respiratory Syncytial Virus: The Time Has ComeThe Journal of Infectious Diseases, 2016
- Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysisJournal of Clinical Microbiology, 2015
- Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome SequencingJournal of Virology, 2015
- Identification of group B respiratory syncytial viruses that lack the 60‐nucleotide duplication after six consecutive epidemics of total BA dominance at coastal KenyaInfluenza and Other Respiratory Viruses, 2013
- The Burden of Hospitalized Lower Respiratory Tract Infection due to Respiratory Syncytial Virus in Rural ThailandPLOS ONE, 2010
- Ten Years of Global Evolution of the Human Respiratory Syncytial Virus BA Genotype with a 60-Nucleotide Duplication in the G Protein GeneJournal of Virology, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- The impact of laboratory characteristics on molecular detection of respiratory syncytial virus in a European multicentre quality control studyClinical Microbiology and Infection, 2008
- Comparison of Real-Time PCR Assays with Fluorescent-Antibody Assays for Diagnosis of Respiratory Virus Infections in ChildrenJournal of Clinical Microbiology, 2006